{"member_organisations": "", "identification_number": "10184967810-77", "fields_of_interest": "Trade, Consumers, Research and innovation, External Relations, Public Health", "head_office_address": "Industriparken, 55", "full_time_equivalent_fte": "1,25", "person_with_legal_responsibility": "Gitte Pugholm Aabo", "inter_groups": "", "financial_year_start_date": "01/01/2017", "grants": "", "head_office_country": "Denmark", "eu_initiatives": "REACH \nIncentives Review, including Supplementary Protection Certificate (SPC) regulation \nHTA proposal \nFalsified Medicines Directive", "organisation_name": "LEO Pharma A/S (LEO Pharma)", "belgium_office_post_code": "2500", "number_of_persons_involved": "3", "procurement": "", "section": "II - In-house lobbyists and trade/business/professional associations", "source": "", "belgium_office_address": "Duwijckstraat 17", "subsection": "Companies & groups", "belgium_office_phone": "(+32)3 740 78 68", "number_of_ep_accredited_persons": "", "overall_budget_turnover_as_a_range": "", "belgium_office_city": "Lier", "persons_accredited_for_access_to_european_parliament_premises": "", "estimate_of_costs_absolute_amount": "", "registration_date": "23/01/2012", "website_address": "http://www.leo-pharma.com/", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Ballerup", "membership": "Member of the \u200bThe Danish Association of the Pharmaceutical Industry (Lif) \nMember of the International Federation of Pharmaceutical Manufactuers & Associations (IFPMA) \nMember of EFPIA \nMember of Confederation of Danish Industry (DI)", "head_office_post_code": "2750", "goals__remit": "Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company. \n \nLEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. To realise our vision of becoming the preferred dermatology care partner improving people\u2019s lives around the world, we are expanding into new regions and markets, reaching more patients and societies with drugs and therapies that address unmet medical needs.  \n \n LEO Pharma has its own sales forces in 61 countries and employs around 5,000 employees worldwide. The company is headquartered in Denmark and is wholly owned by the LEO Foundation \n \nLEO Pharma\u2019s revenue in 2017 amounted to DKK 10,481 million. The revenue increased by 8% in Danish kroner compared to 2016. LEO Pharma's 2017 profit before interest and taxes (EBIT) amounted to DKK 852 million.", "industry_forums": "", "head_office_phone": "(+45)44945888", "level_of_interest": "global", "relevant_communication": "Meetings with MEPs \nDanish Pharma events in partnership with the Danish Permanent Representation to the EU  \nDisease awareness activities \nWorld Psoriasis Day \nWorld Thrombosis Day \nWorld Eczema Day", "financial_year_end_date": "01/12/2017", "estimate_of_costs_as_a_range": "200000-299999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "Limited company", "person_in_charge_of_eu_relations": "Vibe Balthazar-Christensen", "customers": "", "belgium_office_post_box": "", "position": "Senior Manager Global Public Affairs"}